Yuchun Lee - Apr 4, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Apr 4, 2022
Transactions value $
-$1,080,424
Form type
4
Date filed
4/6/2022, 04:59 PM
Next filing
Apr 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $163K +2K +106.67% $81.54 3.88K Apr 4, 2022 Direct
transaction VRTX Common Stock Sale -$26.6K -100 -2.58% $265.83 3.78K Apr 4, 2022 Direct F1
transaction VRTX Common Stock Sale -$245K -917 -24.29% $267.23 2.86K Apr 4, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$264K -983 -34.39% $268.36 1.88K Apr 4, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Options Exercise $163K +2K +106.67% $81.54 3.88K Apr 5, 2022 Direct
transaction VRTX Common Stock Sale -$4.56K -17 -0.44% $268.30 3.86K Apr 5, 2022 Direct F1
transaction VRTX Common Stock Sale -$90.2K -334 -8.66% $270.05 3.52K Apr 5, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$133K -488 -13.85% $271.94 3.04K Apr 5, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$164K -600 -19.76% $272.60 2.44K Apr 5, 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$27.4K -100 -4.11% $273.50 2.34K Apr 5, 2022 Direct F1
transaction VRTX Common Stock Sale -$127K -461 -19.73% $274.66 1.88K Apr 5, 2022 Direct F1, F2, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise -$163K -2K -10% $81.54 18K Apr 4, 2022 Common Stock 2K $81.54 Direct F9
transaction VRTX Stock Option (Right to Buy) Options Exercise -$163K -2K -11.11% $81.54 16K Apr 5, 2022 Common Stock 2K $81.54 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79).
F4 Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81).
F5 Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64).
F6 Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27).
F7 Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34).
F8 Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68).
F9 Fully vested.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney